HomeOLMA • NASDAQ
add
Olema Pharmaceuticals Inc
Previous close
$8.00
Day range
$7.75 - $8.20
Year range
$2.86 - $13.93
Market cap
533.29M USD
Avg Volume
841.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 37.86M | 12.93% |
Net income | -43.78M | -44.11% |
Net profit margin | — | — |
Earnings per share | -0.51 | 5.56% |
EBITDA | -37.73M | -12.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 361.91M | 51.36% |
Total assets | 382.00M | 50.07% |
Total liabilities | 36.77M | 34.21% |
Total equity | 345.24M | — |
Shares outstanding | 68.63M | — |
Price to book | 1.59 | — |
Return on assets | -23.91% | — |
Return on capital | -25.77% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -43.78M | -44.11% |
Cash from operations | -29.88M | -8.45% |
Cash from investing | 34.23M | 801.80% |
Cash from financing | -2.52M | -116.14% |
Net change in cash | 1.83M | 110.89% |
Free cash flow | -13.72M | 7.57% |
About
Founded
2006
Headquarters
Website
Employees
117
